Stock Chart

EW

$85.19 -1.31%
Score: 57.1 HOLD
LEAPs: SELL $80
i
LEAPs Option Signal

Type: SELL growth_1yr
Strike: $80
Premium: $20.00
Expiry: Sep 17, 2027
Target: $85
Score: -73

LEAPs are long-term options (1+ year) with less time decay.
Pro
Screener
Vol: 0.90x (vs SPY: 0.9x | vs QQQ: 0.8x)
Volume Ratio Explained

Vol: Current volume vs 20-day average
vs SPY: Relative activity vs market
vs QQQ: Relative activity vs tech

Color Guide:
● Red (≥1.5x): High activity
● Yellow (≥1.2x): Above average
● Blue (≤0.7x): Low activity

Interpretation:
• vs SPY > 1: Stock-specific interest
• vs SPY < 1: Stock quiet vs market
Chart Pattern · as of Oct 01, 2026
Falling Channel weak / forming — below our quality gate quality 55/100
A Falling Channel is taking shape but hasn't passed our quality gate (60/100), so no projected path or levels are shown — only the forming rails on the chart below.
Historically breaks up 64% of the time; target hit in 60% of up-breaks (n=559)
Technical Chart
OVERLAYS
INDICATORS
TRENDLINES
OPTIONS FLOW
VOLUME & PRICE
OTHER
SETTINGS
Active (2)
CHART OVERLAYS
Active: 2
INDICATORS
TRENDLINES
OPTIONS FLOW
VOLUME & PRICE
OTHER

About EW - Edwards Lifesciences Corp

Spun off from Baxter International in 2000, Edwards Lifesciences designs, manufactures, and markets a range of medical devices and equipment for advanced stages of structural heart disease. It has established itself as a leader across key products, including surgical tissue heart valves, transcatheter aortic valves, and transcatheter mitral and tricuspid valve technologies. The firm derives about 60% of its total sales from outside the US.

Key Statistics

Market Cap $51B
P/E Ratio 52.43

More EW Analysis

Buy or Sell Analysis Price Prediction AI Analysis Fair Price Options Advisor Trendline Analysis

This EW stock chart provides comprehensive technical analysis including candlestick patterns, volume profile analysis, and options open interest data. Track EW's price movements with trendlines, gamma walls, and key support/resistance levels.